Alert detail
FDA Approval: ALECENSA (ALECTINIB HYDROCHLORIDE) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA208434Specialty: OncologyAdded: 6/17/2026Effective: 2015-12-11federal register
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.